グリオブラストーマの化学療法耐性を克服するための道筋を探る(Charting a path toward overcoming glioblastoma resistance to chemotherapy)

ad

2024-12-19 韓国基礎科学研究院(IBS)

IBSの研究者たちは、膠芽腫(GBM)の化学療法抵抗性を克服するための新たなアプローチを開発しました。彼らは、GBM細胞が化学療法薬であるテモゾロミド(TMZ)に対して抵抗性を示すメカニズムを解明し、特定の分子経路を標的とすることで、この抵抗性を効果的に抑制できることを発見しました。この研究は、GBM治療の新たな戦略を提供し、患者の予後改善に寄与する可能性があります。

<関連情報>

包括的全ゲノム配列決定により、加齢、ミスマッチ修復欠損、テモゾロミド化学療法に関連する変異シグネチャーの起源が明らかになった Comprehensive whole-genome sequencing reveals origins of mutational signatures associated with aging, mismatch repair deficiency and temozolomide chemotherapy

Taejoo Hwang, Lukasz Karol Sitko, Ratih Khoirunnisa, Fernanda Navarro-Aguad, David M Samuel, Hajoong Park, Banyoon Cheon, Luthfiyyah Mutsnaini, Jaewoong Lee, Burçak Otlu
Nucleic Acids Research  Published:05 December 2024
DOI:https://doi.org/10.1093/nar/gkae1122

グリオブラストーマの化学療法耐性を克服するための道筋を探る(Charting a path toward overcoming glioblastoma resistance to chemotherapy)
Graphical Abstract

Abstract

In a comprehensive study to decipher the multi-layered response to the chemotherapeutic agent temozolomide (TMZ), we analyzed 427 genomes and determined mutational patterns in a collection of ∼40 isogenic DNA repair-deficient human TK6 lymphoblast cell lines. We first demonstrate that the spontaneous mutational background is very similar to the aging-associated mutational signature SBS40 and mainly caused by polymerase zeta-mediated translesion synthesis (TLS). MSH2-/- mismatch repair (MMR) knockout in conjunction with additional repair deficiencies uncovers cryptic mutational patterns. We next report how distinct mutational signatures are induced by TMZ upon sequential inactivation of DNA repair pathways, mirroring the acquisition of chemotherapy resistance by glioblastomas. The most toxic adduct induced by TMZ, O6-meG, is directly repaired by the O6-methylguanine-DNA methyltransferase (MGMT). In MGMT-/- cells, MMR leads to cell death and limits mutagenesis. MMR deficiency results in TMZ resistance, allowing the accumulation of ∼105 C > T substitutions corresponding to signature SBS11. Under these conditions, N3-methyladenine (3-meA), processed by base excision repair (BER), limits cell survival. Without BER, 3-meA is read through via error-prone TLS, causing T > A substitutions but not affecting survival. Blocking BER after abasic site formation results in large deletions and TMZ hypersensitization. Our findings reveal potential vulnerabilities of TMZ-resistant tumors.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました